HIGHLIGHTS
- who: Paola Salari et al. from the Institute of Pharmaceutical Medicine (ECPM), University of Basel, Basel, Switzerland, Pharmaceutical have published the article: Cost-effectiveness of a structured medication review approach for multimorbid older adults: Within-trial analysis of the OPERAM study, in the Journal: PLOS ONE of 11/04/2022
- what: Clinical results of the trial showed a pattern of reduced drug-related hospital admissions but without statistical significance. The authors assessed the cost-effectiveness of the pharmacotherapy optimisation intervention. Based on the health economic data collected in the OPERAM trial, the focus of the . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.